Close Menu

This article has been updated from a previous version to clarify that Luminex's assay is qualitative.

NEW YORK – Luminex announced after the close of the market on Monday that it has submitted an application for clearance to the US Food and Drug Administration for its Aries MRSA Assay.

The assay is a real-time, qualitative polymerase chain reaction test for the direct detection of methicillin-resistant Staphylococcus aureus (MRSA) DNA from nasal swabs in patients at risk for nasal colonization.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Genetic genealogy has helped exonerate a man who has been jailed for 20 years, Agence France Presse reports.

NPR reports that many USDA researchers working at the two agencies that are relocating to the Kansas City area are declining to go.

A new report says genetically modified food might be necessary to be able to feed a planet of nearly 10 billion people, Bloomberg says.

In Nature this week: new RNA editing approach called LEAPER, draft assembly of Musa balbisiana banana genome, and more.